Global Genitourinary Collaboration and Licensing Agreement Analysis Report 2023 with Directory of Deals Signed by the World’s Leading Biopharma Companies Since 2016
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Genitourinary Collaboration and Licensing Deals 2016-2023” report has been added to ResearchAndMarkets.com’s offering. Genitourinary Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access
Global Immunology Collaboration and Licensing Agreements Analysis Report 2023 with Directory of Deals Signed by the World’s Leading Biopharma Companies Since 2016
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Immunology Collaboration and Licensing Deals 2016-2023” report has been added to ResearchAndMarkets.com’s offering. Immunology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the
Global Cloud in Healthcare User Survey Report 2023 – Rapid Pace of Technology Change in Healthcare Cloud Implementation
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Global Cloud User Survey, Q3, 2022” report has been added to ResearchAndMarkets.com’s offering. This global annual cloud survey’s primary goal is to determine cloud computing technology adoption among healthcare organizations,
Harbour City Shopping Mall in Hong Kong hosted a lighting ceremony to launch its “Merry Spacemas” Outdoor Christmas Decoration
HONG KONG, Nov. 18, 2023 /PRNewswire/ — Christmas is one of the most celebrated holidays in Hong Kong. Harbour City, the largest shopping mall in Hong Kong, has hosted a lighting ceremony to launch its iconic outdoor Christmas decoration display under the theme of “Merry Spacemas”
3 Day GMP (Good Manufacturing Practices) Virtual Master Class: Get it Right to Avoid Compliance Issues
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “GMP Master Class – Get it Right to Avoid Compliance Issues” training has been added to ResearchAndMarkets.com’s offering. CGMPs or Current Good Manufacturing Practices is a general encompassing term for the regulations that t
1 Day Virtual Drug Safety & Pharmacovigilance Regulatory Requirements Training Course: Learn Product Safety Regulatory Requirements for the US and EU
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “Global Regulatory Requirements for Drug Safety & Pharmacovigilance” training has been added to ResearchAndMarkets.com’s offering. This training course is designed to give pharmaceutical and biologic companies operating in the US
Robert D. Botticelli, Director of Business Development for Century Fasteners Corp., Honored by ADDAPT
Robert D. Botticelli, Honored by the ADDAPT Organization, Founders and Futures Night. ELMHURST, N.Y., Nov. 17, 2023 /PRNewswire/ — Robert D. Botticelli, Director of Business Development at Century Fasteners Corp., is being honored by the ADDAPT Defense and Aerospace Organization with the ̶
United States Small Household Appliances Market Report 2023: Growing Trend of Single Living Spurs Demand for Time-Saving Appliances
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “The US Small Household Appliances Market (by Category, Product, & Distribution Channel): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)” report has been added to ResearchAndMarkets.com’s offering. The US sma
Global AI In Patient Engagement Research Report 2023: Market to Reach $23.1 Billion by 2030 at a CAGR of 21% – Expanding Applications Across Diagnostics and Patient Engagement
DUBLIN, Nov. 17, 2023 /PRNewswire/ — The “AI In Patient Engagement Market Size, Share & Trends Analysis Report By Technology (NLP, Chatbots), By End-use (Providers, Payers), By Delivery Type, By Functionality, By Therapeutic Area, By Application, And Segment Forecasts, 2023 –
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of General Motors Company – GM
NEW YORK, Nov. 17, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of General Motors Company (“GM” or the “Company”) (NYSE: GM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529
